22 December 2021. China’s domestically developed monoclonal neutralizing antibody therapy for COVID-19 treatment could be used clinically in the country within weeks after it was included in the country’s Diagnosis and Treatment Protocol for COVID-19－adding a tool to the global arsenal against the coronavirus.https://www.chinadaily.com.cn/a/202112/22/WS61c26000a310cdd39bc7cbd1.html